|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61M 5/00 | |
| A61K 9/00 | |||
| A61K 47/34 | |||
| A61K 9/10 | |||
| A61K 9/16 | |||
| A61K 31/4422 | |||
| A61K 31/4439 | |||
| A61K 31/4545 | |||
| A61K 31/496 |
| (11) | Number of the document | 2694133 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12767399.4 |
| Date of filing the European patent application | 2012-04-05 | |
| (97) | Date of publication of the European application | 2014-02-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/032317 |
| Date | 2012-04-05 |
| (87) | Number | WO 2012/138854 |
| Date | 2012-10-11 |
| (30) | Number | Date | Country code |
| 201161471779 P | 2011-04-05 | US |
| (72) |
MACDONALD, R. Loch, US
LEUTHNER, Brian A., US
|
| (73) |
Edge Therapeutics, Inc.,
300 Connell Drive, Berkeley Heights, NJ 07922,
US
|
| (54) | INTRAVENTRICULAR DRUG DELIVERY SYSTEM FOR IMPROVING OUTCOME AFTER A BRAIN INJURY AFFECTING CEREBRAL BLOOD FLOW |
| INTRAVENTRICULAR DRUG DELIVERY SYSTEM FOR IMPROVING OUTCOME AFTER A BRAIN INJURY AFFECTING CEREBRAL BLOOD FLOW |